NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$42.43
+0.220 (+0.521%)
At Close: May 09, 2024
Amphastar Pharmaceuticals Q1 Adj. EPS $0.170 Beats $0.080 Estimate, Sales $84.688M Beat $82.830M Estimate
08:27pm, Thursday, 07'th May 2020Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
08:05pm, Thursday, 07'th May 2020
RANCHO CUCAMONGA, Calif., May 07, 2020 -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March.
Why the Earnings Surprise Streak Could Continue for Amphastar (AMPH)
04:10pm, Wednesday, 06'th May 2020
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why the Earnings Surprise Streak Could Continue for Amphastar (AMPH)
12:00am, Wednesday, 06'th May 2020Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
10:01am, Monday, 04'th May 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced that the Company will release results for its first quarter of 2020 ended March 31, 2020, after the market closes on Thursday, May 7th, 2020, and will
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:18pm, Friday, 01'st May 2020
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:18pm, Friday, 01'st May 2020
Needham analyst Serge Belanger assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report) today and set a price
Northland Securities Keeps Their Buy Rating on Amphastar Pharmaceuticals (AMPH)
11:34am, Friday, 01'st May 2020
Northland Securities analyst Tim Chiang maintained a Buy rating on Amphastar Pharmaceuticals (AMPH) today and set a price target of $23.00. The company's
Northland Securities Keeps Their Buy Rating on Amphastar Pharmaceuticals (AMPH)
11:34am, Friday, 01'st May 2020
Northland Securities analyst
Tim Chiang
maintained a
Buy
rating on Amphastar Pharmaceuticals (
AMPH
–
Research Report
) today and set a price target of
$23.00
. The company’s shares closed last Th
Needham Maintains a Buy Rating on Flexion Therapeutics (FLXN)
09:53am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN) today and set a price target of $30.00. The company's shares closed
Needham Maintains a Buy Rating on Flexion Therapeutics (FLXN)
09:53am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN – Research Report) today and set a price
Needham Thinks Aerie Pharma's Stock is Going to Recover
09:52am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $38.00. The company's shares closed last
Needham Thinks Aerie Pharma’s Stock is Going to Recover
09:52am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price
Pacira Pharmaceuticals (PCRX) Received its Third Buy in a Row
09:46am, Thursday, 30'th Apr 2020
After Northland Securities and Wedbush gave Pacira Pharmaceuticals (NASDAQ: PCRX) a Buy rating last month, the company received another Buy, this time
Pacira Pharmaceuticals (PCRX) Received its Third Buy in a Row
09:46am, Thursday, 30'th Apr 2020
After Northland Securities and Wedbush gave Pacira Pharmaceuticals (NASDAQ: PCRX) a Buy rating last month, the company received another Buy,
